 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 4.34 |
9.32 % |
$ 10.4 B |
Australia |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
58.1 |
$ 310.78 |
-2.92 % |
$ 40.7 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 22.7 |
4.08 % |
$ 1.06 B |
USA |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
16.8 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 |
$ 3.04 |
-1.3 % |
$ 5 M |
Israel |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
BioXcel Therapeutics
BTAI
|
103 |
$ 1.18 |
9.81 % |
$ 14.4 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
62.9 |
$ 1.44 |
6.67 % |
$ 370 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Aquestive Therapeutics
AQST
|
103 |
$ 4.36 |
2.35 % |
$ 466 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 |
$ 24.65 |
1.9 % |
$ 3.14 B |
USA |
 |
Celldex Therapeutics
CLDX
|
321 |
$ 34.97 |
3.28 % |
$ 2.32 B |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
58.2 |
$ 1.65 |
2.48 % |
$ 439 M |
Britain |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
2.47 |
- |
- |
$ 546 M |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
Cidara Therapeutics
CDTX
|
2.26 K |
- |
- |
$ 1.41 B |
USA |
 |
CymaBay Therapeutics
CBAY
|
182 |
- |
- |
$ 3.45 B |
USA |